Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$269M |
| 2 |
Amazon
AMZN
|
+$242M |
| 3 |
Apple
AAPL
|
+$215M |
| 4 |
Amgen
AMGN
|
+$212M |
| 5 |
Citizens Financial Group
CFG
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$210M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$195M |
| 3 |
iShares GSCI Commodity Dynamic Roll Strategy ETF
COMT
|
+$154M |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$127M |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$115M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.58% |
| 2 | Financials | 13.47% |
| 3 | Healthcare | 12.09% |
| 4 | Consumer Discretionary | 10.78% |
| 5 | Industrials | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2626
Entravision Communication
EVC
$820M
| $2.71M | ﹤0.01% |
381,072
+231,276
| +154% | +$1.56M |
|
|
PAE
2627
DELISTED
PAE Incorporated Class A Common Stock
PAE
| $2.71M | ﹤0.01% |
452,264
+3,896
| +0.9% | +$29.8K |
|
|
JOBS
2628
DELISTED
51job Inc
JOBS
| $2.7M | ﹤0.01% |
38,829
+1,132
| +3% | +$83.3K |
|
|
APPH
2629
DELISTED
AppHarvest, Inc. Common Stock
APPH
| $2.69M | ﹤0.01% |
411,896
+19,459
| +5% | +$193K |
|
2630
Ducommun
DCO
$3.01B
| $2.67M | ﹤0.01% |
53,106
+102
| +0.2% | +$5.35K |
|
2631
Pliant Therapeutics
PLRX
$66.9M
| $2.67M | ﹤0.01% |
158,161
+63,282
| +67% | +$1.34M |
|
2632
Krispy Kreme
DNUT
$569M
| $2.65M | ﹤0.01% |
+189,306
| New | +$3.04M |
|
2633
BARK
BARK
$94.3M
| $2.64M | ﹤0.01% |
+19,264
| New | +$3.18M |
|
2634
Clear Secure
YOU
$4.7B
| $2.64M | ﹤0.01% |
+64,392
| New | +$3.01M |
|
2635
Ooma
OOMA
$574M
| $2.63M | ﹤0.01% |
141,582
+59,862
| +73% | +$1.13M |
|
2636
Prelude Therapeutics
PRLD
$428M
| $2.63M | ﹤0.01% |
83,985
+11,362
| +16% | +$368K |
|
2637
Theravance Biopharma
TBPH
$878M
| $2.6M | ﹤0.01% |
351,793
-4,751
| -1% | -$53.1K |
|
|
CURO
2638
DELISTED
CURO Group Holdings Corp.
CURO
| $2.6M | ﹤0.01% |
149,843
+26,400
| +21% | +$434K |
|
2639
Aspen Aerogels
ASPN
$504M
| $2.59M | ﹤0.01% |
56,326
-1,471
| -3% | -$58.3K |
|
|
PLYM
2640
DELISTED
Plymouth Industrial REIT
PLYM
| $2.58M | ﹤0.01% |
113,247
-10,837
| -9% | -$243K |
|
|
APR
2641
DELISTED
Apria, Inc. Common Stock
APR
| $2.58M | ﹤0.01% |
69,364
+16,719
| +32% | +$550K |
|
2642
Byrna Technologies
BYRN
$97.6M
| $2.58M | ﹤0.01% |
117,802
+31,518
| +37% | +$780K |
|
2643
Titan International
TWI
$438M
| $2.56M | ﹤0.01% |
357,716
+9,482
| +3% | +$74.9K |
|
2644
FRP Holdings
FRPH
$425M
| $2.55M | ﹤0.01% |
91,200
+2,260
| +3% | +$64.9K |
|
|
BHR
2645
Braemar Hotels & Resorts
BHR
$139M
| $2.55M | ﹤0.01% |
524,964
+253,610
| +93% | +$1.32M |
|
|
NBP
2646
NovaBridge Biosciences American Depositary Shares
NBP
$220M
| $2.53M | ﹤0.01% |
+34,860
| New | +$2.52M |
|
|
AHT
2647
Ashford Hospitality Trust
AHT
$20.2M
| $2.52M | ﹤0.01% |
17,101
+7,660
| +81% | +$1.3M |
|
2648
Ocular Therapeutix
OCUL
$2.22B
| $2.51M | ﹤0.01% |
250,841
+1,416
| +0.6% | +$15.9K |
|
2649
Mitek Systems
MITK
$853M
| $2.51M | ﹤0.01% |
135,509
-94,382
| -41% | -$1.91M |
|
2650
LegalZoom.com
LZ
$993M
| $2.51M | ﹤0.01% |
+94,922
| New | +$3.34M |
|
Similar funds
Charles Schwab's Q3 2021 Portfolio in Review
As of Q3 2021, Charles Schwab held 3,610 positions worth $306B, up 1.6% from $301B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q3 2021 filing shows 202 new, 2,185 increased, 922 reduced and 109 closed positions. Its largest new stake was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M. The largest sale was Vanguard FTSE Emerging Markets ETF, an estimated $210M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q3 2021 buy was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M.
- Charles Schwab added most to Moderna in Q3 2021, an estimated $269M increase.
- Charles Schwab's biggest Q3 2021 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $210M.
- Charles Schwab fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $195M.
- Charles Schwab's ten largest holdings make up 17% of its $306B portfolio in Q3 2021.
- Charles Schwab opened 202 new positions and closed 109 in Q3 2021.
- Charles Schwab's portfolio value rose 1.6% quarter-over-quarter to $306B.
Based on Charles Schwab's 13F filing for Q3 2021, filed 16 Nov 2021.